Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate

ClinicalTrials.gov ID: NCT00282308

Public ClinicalTrials.gov record NCT00282308. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Parallel-group, Open-label, Multicenter Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate

Study identification

NCT ID
NCT00282308
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
103 participants

Conditions and interventions

Interventions

  • Rituximab Drug
  • Methotrexate Drug
  • Methylprednisone Drug
  • C. albicans Biological
  • Tetanus toxoid adsorbed booster vaccine Biological
  • 23-valent pneumococcal polysaccharide vaccine Biological
  • Keyhole limpet hemocyanin Biological

Drug · Biological

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 22, 2006
Primary completion
Jan 30, 2008
Completion
May 27, 2012
Last update posted
Aug 9, 2017

2006 – 2012

United States locations

U.S. sites
34
U.S. states
21
U.S. cities
30
Facility City State ZIP Site status
Univ of Alabama at Birmingham Birmingham Alabama 35294
Arizona Arthritis & Rheumatology Research, Pllc Paradise Valley Arizona 85253
Sun Valley Arthritis Center Peoria Arizona 85381
Desert Medical Advances Palm Desert California 92260
Inland Rheumatology; Clinical Trials, Inc. Upland California 91786
Arthritis Associates of South Florida Delray Beach Florida 33484
The Arthritis Center Palm Harbor Florida 34684
Center For Arthritis; Research Dept South Miami Florida 33143
Intermountain Orthopaedics Boise Idaho 83702
Northwestern University Chicago Illinois 60611
Univ of Chicago Chicago Illinois 60637
Evanston Northwestern Healthcare Evanston Illinois
Springfield Clinic Springfield Illinois 62703
Kentuckiana Center For Better Bone & Joint Healthx Louisville Kentucky 40202
Clinical Research Network Slidell Louisiana 70458
Johns Hopkins University; Rheumatology Baltimore Maryland 21224
Dana Farber Cancer Institute Boston Massachusetts 02215
Rheumatology, P.C.; Medical Arts Building Kalamazoo Michigan 49009
Borgess Research Institute Kalamazoo Michigan 49048
Justus Fiechtner MD - PP Lansing Michigan 48910
Center for Rheumatology, State Uni. of New York Albany New York 12206
Aair Research Center Rochester New York 14618
University of Rochester - Strong Memorial Hospital Rochester New York 14642
Physicians East Pa Greenville North Carolina 27834
Health Research of Oklahoma, Llc Oklahoma City Oklahoma 73103
Oregon Health Sciences Uni Portland Oregon 97239
Altoona Arthritis & Osteo Center Duncansville Pennsylvania 16635
University of Pennsylvania Philadelphia Pennsylvania 19104
Rheumatology Associates Charleston South Carolina 29407
Medical University of S. Carolina Charleston South Carolina 29425
Arthritis Associates Hixson Tennessee 37343
Arthritis Care & Diagnostic Center Dallas Texas 75231-4406
Arthritis Clinic of Northern Virginia Arlington Virginia 22205
Arthritis Northwest, Spokane Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00282308, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00282308 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →